Dosage
Ivermectin Dosage represents the quantitative, weight-adjusted administration schedules (typically 150–200 mcg/kg for approved human indications) and timing parameters calibrated to achieve therapeutic blood serum concentrations while minimizing neurotoxic and gastrointestinal risks.
Foundational Clinical Guides (Start Here)
Do you take ivermectin with food? Maximize Effectiveness and Minimize Risks
Clinical analysis and evidence-based reference guide covering indications, administration protocols, and safety parameters.
How often should I take ivermectin? Expert Recommendations
Clinical analysis and evidence-based reference guide covering indications, administration protocols, and safety parameters.
How Long Does Ivermectin Take to Work? Timelines Explained
Clinical analysis and evidence-based reference guide covering indications, administration protocols, and safety parameters.
Should you take ivermectin with food? Dosage Tips for Best Results
Clinical analysis and evidence-based reference guide covering indications, administration protocols, and safety parameters.
Pharmacokinetic Profiles, Milligram-per-Kilogram Calibrations, and Food-Effect Dynamics
Ivermectin dosing operates on weight-based pharmacokinetics ($mu ext{g/kg}$ body mass) rather than static tablet administration. For adult and pediatric patients weighing $ge 15 ext{ kg}$, the standard single oral dose for uncomplicated intestinal strongyloidiasis is approximately $200 ext{ }mu ext{g/kg}$, whereas onchocerciasis protocols typically utilize $150 ext{ }mu ext{g/kg}$ administered at 6- to 12-month intervals. Achieving correct systemic exposure is critical: subtherapeutic levels risk treatment failure and pathogen persistence, whereas excessive dosage can overwhelm P-glycoprotein blood-brain barrier defenses.
Food intake significantly influences oral bioavailability. Administering ivermectin with a high-fat meal increases peak plasma concentrations ($C_{max}$) and area under the curve ($ ext{AUC}$) by approximately 2.5-fold compared to fasting conditions. While fasting administration is standard for luminal gastrointestinal helminths to maintain drug presence within the gut, dermatological conditions (such as scabies and demodex) may benefit from enhanced systemic absorption under medical supervision. The evaluation matrix below establishes reference dosing parameters.
| Indication / Subject | Standard Dosage Metric | Administration Schedule & Timing Parameters |
|---|---|---|
| Strongyloidiasis (Human) | ~200 mcg/kg body weight | Single oral dose with water; follow-up stool examinations at 1 and 3 months |
| Onchocerciasis (Human) | ~150 mcg/kg body weight | Single oral dose repeated every 6 to 12 months until microfilariae clear |
| Sarcoptic Scabies (Human) | 200 mcg/kg body weight | Two doses administered exactly 7–14 days apart to eradicate newly hatched nymphs |
| Feline Ectoparasites (Veterinary) | 200–300 mcg/kg body weight | Strict veterinary calculation; highly toxic in low-weight kittens |
| Canine Heartworm Prophylaxis | 6 mcg/kg body weight | Strictly micro-dosed monthly tablet; fatal if dosed at livestock anthelmintic levels |
Topic Directory & Specialized Research Chapters
Human Weight-Adjusted Calculations & Frequency
Pharmacokinetic Timing & Food Bioavailability
Frequently Asked Questions & Expert Guidance
Should ivermectin tablets be taken with meals or on an empty stomach?
For intestinal parasites like strongyloidiasis, clinical guidelines recommend taking tablets with water on an empty stomach (at least 2 hours before or after eating). For tissue-dwelling parasites, taking with food increases absorption, but must be directed by a physician.
How long does ivermectin remain active in human blood plasma?
The plasma elimination half-life of ivermectin in healthy adults averages 16 to 18 hours. However, active lipophilic metabolites concentrate in adipose and dermal tissues, exerting prolonged antiparasitic action over several days.
What are the dangers of daily ivermectin administration?
Approved human dosing relies on single doses or pulses separated by 7 to 14 days. Daily continuous dosing leads to hepatic bioaccumulation, neurotoxicity (ataxia, confusion, visual disturbances), and potentially fatal metabolic derangement.









